Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating activities:
Net loss	$ (6,531)	$ (25,021)
Adjustments required to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	377	317
Stock-based compensation expense	781	534
Change in fair value of the Convertible Loan	(5,203)	13,025
Non-cash interest expense	3,596	1,815
Non-cash interest income		(26)
Change in right-of-use asset	597	464
Changes in operating assets and liabilities:
Prepaid expenses and other assets	539	1,797
Accounts payable and accrued liabilities	(553)	(1,488)
Accrued compensation	(933)	180
Operating lease liability	(250)	(2,181)
Net cash used in operating activities	(7,580)	(10,584)
Investing activities:
Purchases of property and equipment	(99)	(250)
Net cash used in investing activities	(99)	(250)
Financing activities:
Proceeds from issuance of term debt, net of issuance costs	10,000	34,889
Payments for taxes related to net share settlement of equity awards	(14)
Proceeds from exercise of stock options		42
Net cash provided by financing activities	9,986	34,931
Net increase in cash, cash equivalents and restricted cash	2,307	24,097
Cash, cash equivalents and restricted cash, beginning of period	14,771	19,243
Cash, cash equivalents and restricted cash, end of period	17,078	43,340
Supplemental disclosure of cash flow information:
Unpaid debt issuance costs		26
Property and equipment included in accounts payable and accrued liabilities	$ 9	$ 425